Expression of GABRG3, GABRQ, GABRE, and GABRR2 is correlated with inhibition of growth phenotypes in cell lines and with favorable patient outcomes [106,107,108] (Broad Institute of MIT & Harvard, firebrowse.org), while expression of other transcripts (GABRB2, GABRP) is associated with cancer progression [109,110,111]. Here, GABRB2 is linked to cancer.